O	0	9	Promotion	Promotion	NN	B-NP
O	10	12	of	of	IN	B-PP
O	13	26	tumorigenesis	tumorigenesis	NN	B-NP
O	27	29	by	by	IN	B-PP
O	30	42	heterozygous	heterozygous	JJ	B-NP
O	43	53	disruption	disruption	NN	I-NP
O	54	56	of	of	IN	B-PP
O	57	60	the	the	DT	B-NP
O	61	67	beclin	beclin	NN	I-NP
O	68	69	1	1	CD	I-NP
O	70	79	autophagy	autophagy	NN	I-NP
O	80	84	gene	gene	NN	I-NP
O	84	85	.	.	.	O

B-Cell	87	96	Malignant	Malignant	JJ	B-NP
I-Cell	97	102	cells	cell	NNS	I-NP
O	103	108	often	often	RB	B-ADVP
O	109	116	display	display	VBP	B-VP
O	117	124	defects	defect	NNS	B-NP
O	125	127	in	in	IN	B-PP
O	128	137	autophagy	autophagy	NN	B-NP
O	137	138	,	,	,	O
O	139	141	an	an	DT	B-NP
O	142	156	evolutionarily	evolutionarily	RB	I-NP
O	157	166	conserved	conserve	VBN	I-NP
O	167	174	pathway	pathway	NN	I-NP
O	175	178	for	for	IN	B-PP
O	179	188	degrading	degrade	VBG	B-VP
O	189	193	long	long	JJ	B-NP
O	193	194	-	-	HYPH	I-NP
O	194	199	lived	lived	JJ	I-NP
O	200	208	proteins	protein	NNS	I-NP
O	209	212	and	and	CC	O
B-Cellular_component	213	224	cytoplasmic	cytoplasmic	JJ	B-NP
I-Cellular_component	225	235	organelles	organelle	NNS	I-NP
O	235	236	.	.	.	O

O	237	244	However	However	RB	B-ADVP
O	244	245	,	,	,	O
O	246	248	as	as	IN	B-PP
O	249	252	yet	yet	RB	B-ADVP
O	252	253	,	,	,	O
O	254	259	there	there	EX	B-NP
O	260	262	is	be	VBZ	B-VP
O	263	265	no	no	DT	B-NP
O	266	273	genetic	genetic	JJ	I-NP
O	274	282	evidence	evidence	NN	I-NP
O	283	286	for	for	IN	B-PP
O	287	288	a	a	DT	B-NP
O	289	293	role	role	NN	I-NP
O	294	296	of	of	IN	B-PP
O	297	306	autophagy	autophagy	NN	B-NP
O	307	312	genes	gene	NNS	I-NP
O	313	315	in	in	IN	B-PP
B-Cancer	316	321	tumor	tumor	NN	B-NP
O	322	333	suppression	suppression	NN	I-NP
O	333	334	.	.	.	O

O	335	338	The	The	DT	B-NP
O	339	345	beclin	beclin	NN	I-NP
O	346	347	1	1	CD	I-NP
O	348	357	autophagy	autophagy	NN	I-NP
O	358	362	gene	gene	NN	I-NP
O	363	365	is	be	VBZ	B-VP
O	366	381	monoallelically	monoallelically	RB	I-VP
O	382	389	deleted	delete	VBN	I-VP
O	390	392	in	in	IN	B-PP
O	393	395	40	40	CD	B-NP
O	395	396	-	-	HYPH	I-NP
O	396	398	75	75	CD	I-NP
O	398	399	%	%	NN	I-NP
O	400	402	of	of	IN	B-PP
O	403	408	cases	case	NNS	B-NP
O	409	411	of	of	IN	B-PP
O	412	417	human	human	JJ	B-NP
O	418	426	sporadic	sporadic	JJ	I-NP
B-Cancer	427	433	breast	breast	NN	I-NP
O	433	434	,	,	,	O
B-Cancer	435	442	ovarian	ovarian	JJ	B-ADJP
O	442	443	,	,	,	O
O	444	447	and	and	CC	O
B-Cancer	448	456	prostate	prostate	NN	B-NP
I-Cancer	457	463	cancer	cancer	NN	I-NP
O	463	464	.	.	.	O

O	465	474	Therefore	Therefore	RB	B-ADVP
O	474	475	,	,	,	O
O	476	478	we	we	PRP	B-NP
O	479	483	used	use	VBD	B-VP
O	484	485	a	a	DT	B-NP
O	486	494	targeted	target	VBN	I-NP
O	495	501	mutant	mutant	JJ	I-NP
O	502	507	mouse	mouse	NN	I-NP
O	508	513	model	model	NN	I-NP
O	514	516	to	to	TO	B-VP
O	517	521	test	test	VB	I-VP
O	522	525	the	the	DT	B-NP
O	526	536	hypothesis	hypothesis	NN	I-NP
O	537	541	that	that	IN	B-SBAR
O	542	553	monoallelic	monoallelic	JJ	B-NP
O	554	562	deletion	deletion	NN	I-NP
O	563	565	of	of	IN	B-PP
O	566	572	beclin	beclin	NN	B-NP
O	573	574	1	1	CD	I-NP
O	575	583	promotes	promote	VBZ	B-VP
O	584	597	tumorigenesis	tumorigenesis	NN	B-NP
O	597	598	.	.	.	O

O	599	603	Here	Here	RB	B-ADVP
O	604	606	we	we	PRP	B-NP
O	607	611	show	show	VBP	B-VP
O	612	616	that	that	IN	B-SBAR
O	617	629	heterozygous	heterozygous	JJ	B-NP
O	630	640	disruption	disruption	NN	I-NP
O	641	643	of	of	IN	B-PP
O	644	650	beclin	beclin	NN	B-NP
O	651	652	1	1	CD	I-NP
O	653	662	increases	increase	VBZ	B-VP
O	663	666	the	the	DT	B-NP
O	667	676	frequency	frequency	NN	I-NP
O	677	679	of	of	IN	B-PP
O	680	691	spontaneous	spontaneous	JJ	B-NP
B-Cancer	692	704	malignancies	malignancy	NNS	I-NP
O	705	708	and	and	CC	O
O	709	720	accelerates	accelerate	VBZ	B-VP
O	721	724	the	the	DT	B-NP
O	725	736	development	development	NN	I-NP
O	737	739	of	of	IN	B-PP
O	740	749	hepatitis	hepatitis	NN	B-NP
O	750	751	B	B	NN	I-NP
O	752	757	virus	virus	NN	I-NP
O	757	758	-	-	HYPH	B-NP
O	758	765	induced	induce	VBN	I-NP
B-Pathological_formation	766	778	premalignant	premalignant	JJ	I-NP
I-Pathological_formation	779	786	lesions	lesion	NNS	I-NP
O	786	787	.	.	.	O

O	788	797	Molecular	Molecular	JJ	B-NP
O	798	806	analyses	analysis	NNS	I-NP
O	807	809	of	of	IN	B-PP
B-Cancer	810	816	tumors	tumor	NNS	B-NP
O	817	819	in	in	IN	B-PP
O	820	826	beclin	beclin	NN	B-NP
O	827	828	1	1	CD	I-NP
O	829	841	heterozygous	heterozygous	JJ	I-NP
O	842	846	mice	mouse	NNS	I-NP
O	847	851	show	show	VBP	B-VP
O	852	856	that	that	IN	B-SBAR
O	857	860	the	the	DT	B-NP
O	861	870	remaining	remain	VBG	I-NP
O	871	875	wild	wild	JJ	I-NP
O	875	876	-	-	HYPH	I-NP
O	876	880	type	type	NN	I-NP
O	881	887	allele	allele	NN	I-NP
O	888	890	is	be	VBZ	B-VP
O	891	898	neither	neither	CC	I-VP
O	899	906	mutated	mutate	VBN	I-VP
O	907	910	nor	nor	CC	I-VP
O	911	919	silenced	silence	VBN	I-VP
O	919	920	.	.	.	O

O	921	932	Furthermore	Furthermore	RB	B-ADVP
O	932	933	,	,	,	O
O	934	940	beclin	beclin	NN	B-NP
O	941	942	1	1	CD	I-NP
O	943	955	heterozygous	heterozygous	JJ	I-NP
O	956	966	disruption	disruption	NN	I-NP
O	967	974	results	result	VBZ	B-VP
O	975	977	in	in	IN	B-PP
O	978	987	increased	increase	VBN	B-NP
B-Cell	988	996	cellular	cellular	JJ	I-NP
O	997	1010	proliferation	proliferation	NN	I-NP
O	1011	1014	and	and	CC	O
O	1015	1022	reduced	reduce	VBN	B-NP
O	1023	1032	autophagy	autophagy	NN	I-NP
O	1033	1035	in	in	FW	B-ADVP
O	1036	1040	vivo	vivo	FW	I-ADVP
O	1040	1041	.	.	.	O

O	1042	1047	These	These	DT	B-NP
O	1048	1056	findings	finding	NNS	I-NP
O	1057	1068	demonstrate	demonstrate	VBP	B-VP
O	1069	1073	that	that	IN	B-SBAR
O	1074	1080	beclin	beclin	NN	B-NP
O	1081	1082	1	1	CD	I-NP
O	1083	1085	is	be	VBZ	B-VP
O	1086	1087	a	a	DT	B-NP
O	1088	1093	haplo	haplo	AFX	I-NP
O	1093	1094	-	-	HYPH	I-NP
O	1094	1106	insufficient	insufficient	JJ	I-NP
B-Cancer	1107	1112	tumor	tumor	NN	I-NP
O	1112	1113	-	-	HYPH	I-NP
O	1113	1123	suppressor	suppressor	NN	I-NP
O	1124	1128	gene	gene	NN	I-NP
O	1129	1132	and	and	CC	O
O	1133	1140	provide	provide	VBP	B-VP
O	1141	1148	genetic	genetic	JJ	B-NP
O	1149	1157	evidence	evidence	NN	I-NP
O	1158	1162	that	that	IN	B-SBAR
O	1163	1172	autophagy	autophagy	NN	B-NP
O	1173	1175	is	be	VBZ	B-VP
O	1176	1177	a	a	DT	B-NP
O	1178	1183	novel	novel	JJ	I-NP
O	1184	1193	mechanism	mechanism	NN	I-NP
O	1194	1196	of	of	IN	B-PP
B-Cell	1197	1201	cell	cell	NN	B-NP
O	1201	1202	-	-	HYPH	B-NP
O	1202	1208	growth	growth	NN	I-NP
O	1209	1216	control	control	NN	I-NP
O	1217	1220	and	and	CC	O
B-Cancer	1221	1226	tumor	tumor	NN	B-NP
O	1227	1238	suppression	suppression	NN	I-NP
O	1238	1239	.	.	.	O

O	1240	1244	Thus	Thus	RB	B-ADVP
O	1244	1245	,	,	,	O
O	1246	1254	mutation	mutation	NN	B-NP
O	1255	1257	of	of	IN	B-PP
O	1258	1264	beclin	beclin	NN	B-NP
O	1265	1266	1	1	CD	I-NP
O	1267	1269	or	or	CC	O
O	1270	1275	other	other	JJ	B-NP
O	1276	1285	autophagy	autophagy	NN	I-NP
O	1286	1291	genes	gene	NNS	I-NP
O	1292	1295	may	may	MD	B-VP
O	1296	1306	contribute	contribute	VB	I-VP
O	1307	1309	to	to	TO	B-PP
O	1310	1313	the	the	DT	B-NP
O	1314	1326	pathogenesis	pathogenesis	NN	I-NP
O	1327	1329	of	of	IN	B-PP
O	1330	1335	human	human	JJ	B-NP
B-Cancer	1336	1343	cancers	cancer	NNS	I-NP
O	1343	1344	.	.	.	O

